PL

Pablo Legoretta

North America, New York, United States, New York

Description

Pablo Legorreta is the CEO and Founder of Royalty Pharma. Formed in 1996, Royalty Pharma is a pioneer in pharmaceutical business and is the ...

Investor Profile

Pablo Legoretta has made 3 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Series Unknown (67%)
  • Grant (33%)

Country Focus

  • United States (67%)
  • Sweden (33%)

Industry Focus

  • Education
  • Higher Education
  • Universities
  • Artificial Intelligence (Ai)
  • Health Care
  • Information Technology
  • Mhealth
  • Mobile Apps
  • Primary And Urgent Care
  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pablo Legoretta frequently co-invest with?

Claure Group
North America, Florida, United States, Miami
Co-Investments: 1
Mangrove Capital Partners
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
Valor Equity Partners
North America, Illinois, United States, Chicago
Co-Investments: 1
Atreides Management
North America, Massachusetts, United States, Boston
Co-Investments: 1

Which angels does Pablo Legoretta often collaborate with?

AL
North America, Rhode Island, United States, Providence
Shared Deals: 1

What are some of recent deals done by Pablo Legoretta?

K Health

New York, New York, United States

K Health is a data-driven digital primary care system that uses AI to deliver personalized primary care services.

Artificial Intelligence (AI)Health CareInformation TechnologymHealthMobile AppsPrimary and Urgent Care
Series UnknownJul 1, 2024
Amount Raised: $88,356,397
Brown University

Providence, Rhode Island, United States

Brown is an independent, coeducational Ivy League institution comprising undergraduate and graduate programs.

EducationHigher EducationUniversities
GrantDec 9, 2021
Amount Raised: $25,000,000
ITBMed

Stockholm, Stockholms Lan, Sweden

A Stockholm, Sweden-based biopharmaceutical company.

BiotechnologyPharmaceutical
Series UnknownApr 5, 2018
Amount Raised: $67,000,000